Trilogy Mets

Forecast & Rating7 analysts currently cover Trilogy Mets, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $6.60, about 75.5% upside from the current price of $3.76. Price targets range from $4.29 to $9.98 — a wide spread, showing clear disagreement over just how much Trilogy Mets can rise. Historically, about 36.6% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Trilogy Mets are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 6, 2026; for reference only and not investment advice.